#EliLilly's CDK4/6 inhibitor #Verzenio reduced the risk of death by 15.8% when used as adjuvant treatment for early-stage HR-positive, HER2-negative #breastcancer, according the reveal of data from the #monarchEtrial.

pharmaphorum.com/news/esmo-li...